SUPRIYA₹818.55-2.12%
65/100
0100 · strongest
good
Weights come from configuration, not from this page — each pillar links to the section below that explains it.
Income stmtHistory
Profitability
headline ratiosGrowth
compounded, from filed annual resultsSegment Results
₹ CrWorking Capital & Efficiency
days · ROCE %SUPRIYA financial summary
For Mar 2026, Supriya Lifescience Ltd reported revenue of ₹828 crore, which grew 19.0% from the previous year. Net profit was ₹209 crore, which grew 11.2% year on year, on an operating margin of 36%. Earnings per share came in at ₹25.98. Annual results are available for 10 financial years, from Mar 2017 to Mar 2026.
| Revenue | ₹828 crore |
|---|---|
| Net profit | ₹209 crore |
| Operating margin | 36% |
| EPS | ₹25.98 |